Retaglutide is a cutting-edge GLP-1 receptor agonist currently under investigation for the management of type 2 diabetes. This therapy works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally https://mariamlyoe687373.blog2freedom.com/39078911/retaglutide-a-promising-glp-1-receptor-agonist